JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
US Judge Dismisses Gautam Adani Criminal Charges 
CBA Posts Record A$10.98B Profit Despite Cautious Outlook 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
ADNOC Gas Targets Up to $4B Profit in 2026 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
ASX Faces Legal Action Over Failed Blockchain CHESS Project 
Samsung, SK Hynix Shares Surge on Report of Potential Temasek Investment 
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Kolmar Korea, a Sejong City-headquartered pharmaceutical preparation manufacturing company, surpassed KRW2 trillion in annual sales for the first time since its founding in 1995. The company reached this milestone due to the immense growth of its subsidiary in China.
The company is looking to expand its market in the United States and will focus on its sunscreen products for this goal. Kolmar Korea can realize this plan as it has already laid the foundations for scaling up its business in the American market.
Targeting Bigger Market Share in the US
As per The Korea Times, Kolmar Korea is speeding up its market expansion in the U.S. market with its sunscreen products. The company prepared for this by obtaining product certification and setting up a new research and development center (R&D).
Kolmar Korea established the facility to better analyze the local consumer market and work on what is best to grow and expand to other regions. The company's primary target today is boosting the sales and demand for its sunscreen in the country since this will equate to success.
It was reported that the largest sunscreen developer in the country is targeting the U.S. because it has the most expansive market for sunscreens.
Big Sucess in China
Meanwhile, as it aims for U.S. expansion, the company is doing well in China. It hit KRW2 trillion in annual sales for the first time. Korea's Consumer News reported that Kolmar Korea said the main reason for the surge in sales was the growth of small and medium-sized indie brands in the country.
It was noted that the firm's ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) are remarkable and played prominent roles in raking in big sales in the territory. Kolmar Korea's Chinese subsidiary also accounts for the second-highest sales share after Korea, so the brand achieved a good performance in 2023.
"A potential for growth in the North American market, including the U.S., is limitless as sunscreen functions are incorporated not only in sunscreens but also in BB creams and foundations," a company official stated. "We plan to actively target the U.S., the world's No. 1 beauty market, not content with just holding a 70 percent share in the domestic sunscreen product market."
Photo by: Kolmar Website
